Constipation
is a disorder that causes issues related to clearing of the bowels
and usually leads to hardened feces. It is especially prevalent among
the elderly and women. Common symptoms of constipation include lumpy
or hard stools, lower abdominal discomfort, straining to have bowel
movements, feeling of blockage in rectum that prevents bowel
movements, and infrequent bowel movements. Factor that can lead to
constipation are aging, dehydration, little or no physical activity,
diet low in fiber, and mental conditions such as depression or eating
disorder. Constipation treatment starts with lifestyle and change in
diet to increase the speed at which stool moves through intestines.
If it doesn’t help then the physician recommend medications or
surgery. Lifestyle and diet change includes increase in fiber intake
and physical activities such as exercise to increase intestinal
muscle activities.
Get
sample copy of this report :
https://www.coherentmarketinsights.com/insight/request-sample/95
Segmentation
of Constipation Treatment Market
Constipation
treatment market is segmented on the basis of type, treatment, method
of administration, and end use. By type, the global constipation
treatment market has been categorized into chronic idiopathic
constipation (CIC), irritable bowel syndrome with constipation
(IBS-C), and opioid-induced constipation (OIC). On the basis of
treatment, the global constipation treatment market has been
categorized into pharmacological treatment and non-pharmacological
treatment, which comprises bowel training for constipation relief,
fluid intake, dietary fiber intake and regular exercise. Further,
pharmacological treatment is categorized into bulk-forming agents,
stool softeners and emollients, osmotic agents, stimulants such as
Bisacodyl, castor oil, senna and Cascara Sagrada, and chloride
channel activators. On the basis of method of administration, the
global constipation treatment market is categorized into oral and
parenteral (subcutaneous injection). On the basis of distribution,
the global constipation treatment market is segmented into hospital
pharmacies, drug stores, and independent pharmacies.
High
prevalence rate in North America drive growth of the Constipation
Treatment Market
High
prevalence rate in North America due to increasing adoption of
unhealthy lifestyle characterized by growing consumption of fast food
is leading to increasing obesity and other related health issues.
This inadvertently leads to high incidence rate of constipation in
the region.
According
to the American Society of Interventional Pain Physicians, the U.S.
accounts for around 80% of the global opioids consumption. According
to an article published in the American Gastroenterological
Association in May 2015, chronic constipation affects one in six
people in the U.S. and is the third-leading symptom prompting
outpatient clinic visits in the country. It is especially prevalent
in overweight women. High acuity information system, high disposable
income level, and rampant adoption of unhealthy lifestyle in Europe
makes it a potential high growth market. Asia Pacific too is expected
to be a lucrative market for constipation treatment, mainly due to
increasing westernization characterized by rising adoption of
non-nutritious fast food in the region.
Request
for table of content :
https://www.coherentmarketinsights.com/ongoing-insight/toc/95
Global
players engaged in the constipation treatment market
The major
players operating in constipation treatment market include
AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott
Laboratories, Valeant Pharmaceuticals International, Inc., C.B. Fleet
Company Inc., Daewoong Co. Ltd., Sucampo Pharmaceuticals Inc., Cosmo
Pharmaceuticals, Synergy Pharmaceuticals Inc. Boehringer Ingelheim
GmbH, and Ironwood Pharmaceuticals.
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
CONTACT
US:
Mr. Shah
Coherent
Market Insights
1001 4th
Ave, #3200
Seattle, WA
98154
Tel :
+1-206-701-6702
No comments:
Post a Comment